# GRANIX

NDC: 63459-920
Generic name: tbo-filgrastim
Labeler / Manufacturer: Cephalon, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20181107

FDA application: BLA125294

## Active ingredients

- FILGRASTIM: 480 ug/1.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63459-920"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63459-920
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df918ec2-0907-443f-a52a-b72866959644